Viewing Study NCT05283356

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:37 PM
Ignite Modification Date: 2026-02-23 @ 1:53 PM
Study NCT ID: NCT05283356
Status: UNKNOWN
Last Update Posted: 2022-03-31
First Post: 2022-03-01
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Single Antiplatelet Treatment With Ticagrelor or Aspirin After Transcatheter Aortic Valve Implantation
Sponsor: Fundacin Biomedica Galicia Sur
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Severe Aortic Valve Stenosis View
None Aortic Valve Stenosis View
None Transcatheter Aortic Valve Replacement (TAVR) View
None Transcatheter Aortic Valve Implantation (TAVI) View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Severe Aortic Valve Stenosis View
None Transcatheter aortic valve replacement (TAVR) View
None Transcatheter aortic valve implantation (TAVI) View
None Single antiplatelet therapy (SAPT) View
None Ticagrelor 60 mg View
None ASA 100 mg View
None Bleeding View
None Valve thrombosis View